METHOD OF DETECTING PROCARBOXYPEPTIDASE A AND CARBOXYPEPTIDASE A LEVELS IN BIOLOGICAL FLUIDS
    1.
    发明公开
    METHOD OF DETECTING PROCARBOXYPEPTIDASE A AND CARBOXYPEPTIDASE A LEVELS IN BIOLOGICAL FLUIDS 失效
    程序用于确定PROCARBOXYPETIDASE-A和羧一面镜子,生物液体

    公开(公告)号:EP0975794A4

    公开(公告)日:2002-12-04

    申请号:EP98914468

    申请日:1998-04-10

    申请人: GILVARG CHARLES

    发明人: GILVARG CHARLES

    摘要: Methods of enhancing sensitivity and specificity of an assay measuring enzymatic activity in a sample by measuring enzymatic activity in the sample in the presence and absence of a specific inhibitor of the enzymatic activity are provided. Methods of measuring carboxypeptidase A levels and total carboxypeptidase A levels, wherein procarboxypeptidase A is converted to carboxypeptidase A by addition of clostripain, in a biological fluid with a carboxypeptidase A substrate, specificity of which is enhanced by addition of a carboxypeptidase A specific inhibitor are also provided. In addition, methods of diagnosing acute pancreatitis by measurement of carboxypeptidase A levels and pancreatic cancer by measurement of total carboxypeptidase A levels are also provided.

    METHOD OF DETECTING PROCARBOXYPEPTIDASE A AND CARBOXYPEPTIDASE A LEVELS IN BIOLOGICAL FLUIDS
    2.
    发明授权
    METHOD OF DETECTING PROCARBOXYPEPTIDASE A AND CARBOXYPEPTIDASE A LEVELS IN BIOLOGICAL FLUIDS 失效
    程序用于确定PROCARBOXYPETIDASE-A和羧一面镜子,生物液体

    公开(公告)号:EP0975794B1

    公开(公告)日:2006-02-22

    申请号:EP98914468.8

    申请日:1998-04-10

    申请人: Gilvarg, Charles

    发明人: Gilvarg, Charles

    IPC分类号: C12Q1/37 C12Q1/00

    摘要: Methods of enhancing sensitivity and specificity of an assay measuring enzymatic activity in a sample by measuring enzymatic activity in the sample in the presence and absence of a specific inhibitor of the enzymatic activity are provided. Methods of measuring carboxypeptidase A levels and total carboxypeptidase A levels, wherein procarboxypeptidase A is converted to carboxypeptidase A by addition of clostripain, in a biological fluid with a carboxypeptidase A substrate, specificity of which is enhanced by addition of a carboxypeptidase A specific inhibitor are also provided. In addition, methods of diagnosing acute pancreatitis by measurement of carboxypeptidase A levels and pancreatic cancer by measurement of total carboxypeptidase A levels are also provided.